SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 6th, 2017 • Generex Biotechnology Corp • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of March ___, 2017, between Generex Biotechnology Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”).
CONVERTIBLE NOTE DUE MARCH ____, 2018Convertible Security Agreement • March 6th, 2017 • Generex Biotechnology Corp • Pharmaceutical preparations • New York
THIS CONVERTIBLE NOTE is one of a series of duly authorized and validly issued Notes of GENEREX BIOTECHNOLOGY CORPORATION, a Delaware corporation, (the “Borrower”), having its principal place of business , 4145 North Service Road, Suite 200, Burlington, Ontario, Canada L7L 6A3, Fax: [RC], due March ___, 2018 (this note, the “Note” and, collectively with the other notes of such series, the “Notes”).
